A multicentre study to assess safety and efficacy of COMP360 in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)
Phase 2
Completed
- Conditions
- treatment resistant depression10027946
- Registration Number
- NL-OMON55052
- Lead Sponsor
- COMPASS Pathfinder Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 3
Inclusion Criteria
1)Signed ICF
2)Each participant having completed the final study visit of either COMP 001 or
COMP 003
3)Ability to complete all protocol required assessment tools (including having
access to the internet in order to complete the digital assessments) without
any assistance or alteration to the copyrighted assessments, and to comply with
all study visits
Exclusion Criteria
1)Subject has any condition, for which in the opinion of the investigator,
participation would not be in the interest of the subject eg participation
could compromise the wellbeing of the participant or prevent, limit, or
confound the protocol-specified assessments
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method